This controversial rule could change how doctors profit from using the most expensive drugs – Washington Post
Medicare’s Cancer Drug Experiment Annoys Specialists – NBC
Read the CMS proposal here and related article from the Motley Fool (9 Drugs That Cost Medicare a Fortune)
News over the weekend
At the start of the weekend, Bloomberg reported that “UnitedHealth Group Inc., the largest U.S. health insurer, has decided to call it quits in two state Obamacare markets. The insurer won’t sell plans for next year in Georgia and Arkansas, according to state insurance regulators. ”
In a column report by the Los Angeles Times however, mentioned “United, which makes most of its money in the large-group (employer) market, always was a reluctant participant in the individual exchanges, and was largely inept at pricing and managing those products. “